Stock AFCAGRO AFC AGRO BIOTECH LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials AFC Agro Biotech Limited

Equities

AFCAGRO

BD0489AFCAB3

Pharmaceuticals

End-of-day quote Dhaka S.E.
Other stock markets
 03:30:00 30/04/2024 am IST 		5-day change 1st Jan Change
13.4 BDT -.--% Intraday chart for AFC Agro Biotech Limited -5.63% -42.98%
2023 AFCAGRO Biotech Limited Enters into an Agreement with Bioneer Corporation to Produce Molecular Diagnostic Kits CI
2023 AFC Agro Biotech Limited Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2023 CI

Valuation

Fiscal Period: June 2017 2018 2019 2020 2021 2022
Capitalization 1 4,508 3,343 3,247 1,959 2,304 2,926
Enterprise Value (EV) 1 4,449 3,401 3,361 2,126 2,445 3,242
P/E ratio 17 x 9.37 x 9.62 x 53.6 x 131 x 114 x
Yield - - - - 0.25% 0.2%
Capitalization / Revenue 4.54 x 3.23 x 2.97 x 3.54 x 5.09 x 4.17 x
EV / Revenue 4.48 x 3.28 x 3.08 x 3.84 x 5.4 x 4.62 x
EV / EBITDA 10.1 x 6.8 x 6.06 x 6.47 x 7.58 x 9.31 x
EV / FCF -145 x -14 x -16 x -31.4 x 122 x -18 x
FCF Yield -0.69% -7.13% -6.25% -3.19% 0.82% -5.56%
Price to Book 3.4 x 1.99 x 1.61 x 0.95 x 1.11 x 1.4 x
Nbr of stocks (in thousands) 1,15,216 1,15,216 1,15,216 1,15,216 1,15,216 1,15,216
Reference price 2 39.13 29.01 28.18 17.00 20.00 25.40
Announcement Date 23/11/17 08/11/18 28/11/19 12/12/20 24/11/21 26/12/22
1BDT in Million2BDT
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2017 2018 2019 2020 2021 2022
Net sales 1 992.5 1,036 1,092 553.8 452.6 701.9
EBITDA 1 439.5 499.8 554.1 328.5 322.7 348.1
EBIT 1 311.3 327.9 330 57.32 31.62 44.7
Operating Margin 31.36% 31.67% 30.23% 10.35% 6.99% 6.37%
Earnings before Tax (EBT) 1 302.4 316.2 340.4 36.58 17.66 25.68
Net income 1 264.6 356.8 337.4 36.51 17.64 25.63
Net margin 26.66% 34.45% 30.91% 6.59% 3.9% 3.65%
EPS 2 2.297 3.097 2.928 0.3169 0.1531 0.2225
Free Cash Flow 1 -30.75 -242.5 -210.1 -67.75 19.98 -180.3
FCF margin -3.1% -23.41% -19.25% -12.23% 4.41% -25.69%
FCF Conversion (EBITDA) - - - - 6.19% -
FCF Conversion (Net income) - - - - 113.21% -
Dividend per Share - - - - 0.0500 0.0500
Announcement Date 23/11/17 08/11/18 28/11/19 12/12/20 24/11/21 26/12/22
1BDT in Million2BDT
Estimates

Balance Sheet Analysis

Fiscal Period: June 2017 2018 2019 2020 2021 2022
Net Debt 1 - 58 114 167 141 315
Net Cash position 1 59.8 - - - - -
Leverage (Debt/EBITDA) - 0.116 x 0.2049 x 0.5091 x 0.4356 x 0.9054 x
Free Cash Flow 1 -30.7 -242 -210 -67.7 20 -180
ROE (net income / shareholders' equity) 22.2% 23.7% 18.2% 1.79% 0.85% 1.23%
ROA (Net income/ Total Assets) 14% 11.8% 9.7% 1.53% 0.84% 1.14%
Assets 1 1,894 3,029 3,480 2,386 2,089 2,240
Book Value Per Share 2 11.50 14.60 17.50 17.90 18.00 18.20
Cash Flow per Share 2 1.330 0.7400 0.6400 0.1000 0.4000 0.6200
Capex 1 380 394 513 317 56.2 95.7
Capex / Sales 38.25% 38.03% 47.02% 57.23% 12.41% 13.64%
Announcement Date 23/11/17 08/11/18 28/11/19 12/12/20 24/11/21 26/12/22
1BDT in Million2BDT
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Biopharmaceuticals

1st Jan change Capi.
AFC AGRO BIOTECH LIMITED Stock AFC Agro Biotech Limited
-42.98% 14.02M
CSL LIMITED Stock CSL Limited
-3.93% 86.16B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+2.76% 40.17B
BIOGEN INC. Stock Biogen Inc.
-17.51% 31.47B
UCB Stock UCB
+54.44% 25.24B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-12.82% 15.82B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.12% 11.96B
INCYTE CORPORATION Stock Incyte Corporation
-15.42% 11.89B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-42.56% 11.61B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+4.87% 8.84B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. AFCAGRO Stock
  4. Financials AFC Agro Biotech Limited